| RET antibodies | |
| This is a review about RET antibodies, based on 5 published articles using RET antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited RET antibody. Information in this review (with links to publications) can be searched freely. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology RET products
includes other brands or spellings
|
| ic, ip, wb | | Santa Cruz Biotechnology anti-human RET antibody was used in western blot, immunoprecipitation and immunocytochemistry to detect RET in CHO cells transfected with the RET/PTC and Myc-PDK1 expression plasmids. |
| ic | | Santa Cruz goat anti-c-Ret antibody was used in immunocytochemistry to study the effect of glial cell line-derived neurotrophic factor and neurturin on neuromuscular synapse development. |
| ih, wb | | Santa Cruz Biotechnology RET (C-20) antibody was used in western blot and immunohistochemistry to study RET expression in anterior pituitary cells and in pituitary tumors. |
| wb | | Santa Cruz Biotechnology anti-RET antibody was used in western blot to study that IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. |
NOVOCASTRA
|
| ih | | Novocastra RET antibody was tested in immunohistochemistry by HPA (CAB002581) . |
Articles Reviewed |
| 1. Chang-Yu Wang et al. Regulation of neuromuscular synapse development by glial cell line-derived neurotrophic factor and neurturin. 2002 |
| 2. Miguel A Japón et al. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors. 2002 |
| 3. Dong Wook Kim et al. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1. 2003 |
| 4. Eun-Joo Kim et al. IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. 2005 |
| 5. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
|